Democritus University of Thrace (DUTH)
Μελέτη των προϊόντων προχωρημένης μη ενζυμικής γλυκοζυλίωσης (AGEs) του δέρματος σε σχέση με τη νευροπάθεια σε ασθενείς με σακχαρώδη διαβήτη τύπου 2
Abstract
dc:descriptionAim of the study: This study aimed to evaluate the correlation between skin advanced glycation end products (AGEs) and neuropathy in subjects with type 2 diabetes mellitus (T2DM). Materials and methods: The study included 132 T2DM subjects (88 men, 44 women) with mean age 64.57±8.21 years. Skin AGEs were measured with the AGE reader mu connect (Diagnoptics) in the dominant arm. Distal symmetric polyneuropathy (DSPN), as well as small- and large nerve fibre dysfunction, were diagnosed by clinical examination through the neuropathy disability score (NDS). Cardiovascular autonomic neuropathy (CAN), as well as sympathetic and parasympathetic nervous system impairment, were diagnosed by the cardiovascular reflex tests (CARTs). Main results: AGEs were higher in the presence of DSPN (p<0.001). Furthermore, they were higher (p<0.05) in the presence of small- or large nerve fibre dysfunction. AGEs were positively correlated with NDS. AGEs were increased in the presence of CAN (p<0.001). Moreover, they were increased in case of abnormal results in each of the 4 CARTs: (Valsalva Ratio: p=0.004, E/I ratio: p=0.001, 30:15 ratio: p=0.011, postural hypotension: p<0.001. As a screening tool for DSPN, AGEs yielded high sensitivity (82.8%) and negative predictive value (NPV) (80.4%). For CAN, they yielded relatively high sensitivity (75.0%) and NPV (74.5%). For sympathetic nervous system impairment, AGEs yielded relatively high sensitivity (75.0%) and high NPV (84.3%). For parasympathetic nervous system impairment, they yielded high PPV (81.0%) with moderately high sensitivity (66.7%).Conclusions: In T2DM, skin AGEs are higher in the presence of both DSPN and CAN. Moreover, they appear useful as a screening tool of these two complications.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papachristou, Stella
- Παπαχρήστου, Στέλλα
Subjects
dc:subject × 12- Διαβητική νευροπάθεια
- προϊόντα προχωρημένης μη ενζυμικής γλυκοζυλίωσης
- Σακχαρώδης διαβήτης
- Advanced glycation end products
- Diabetic neuropathy
- Diabetes mellitus
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ενδοκρινολογία, Διαβήτης και Μεταβολισμός
- Clinical Medicine
- Medical and Health Sciences
- Endocrinology, Diabetes and Metabolism
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54503